Clinical Trials Browser

Completed × Small Cell Lung Carcinoma × belotecan × Clear all

NCT00826644 2021-08-09

COMBAT

Phase 3 Completed

Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT01497873 2018-12-27

A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer

Phase 2 Completed

Small Cell Lung Carcinoma